|
|
Characterization of Orexin/Hypocretin Kinetics in Alzheimers Disease |
| 1 R21 AG074151-01 |
|
NIA |
2021 |
|
|
Trauma Exposure and Cognitive Impairment: Understanding Polygenic Liability and the Causative and Moderating Effects of Exposure, PTSD, and Psychiatric Comorbidity in WTC Responders |
| 1 R21 AG074705-01 |
|
NIA |
2021 |
|
|
Multi-modal cloud based system for detecting early signs of driver cognitive decline and/or high risk driving behaviors |
| 1 R41 AG073222-01 |
|
NIA |
2021 |
|
|
The Role of ICU Delirium and Vascular Risk Factors in the Development of Post-ICU Cognitive Impairment and Dementia |
| 5 K23 AG062555-03 |
|
NIA |
2021 |
|
|
Reversing the epigenetic code of aging through ketogenic diets |
| 5 P01 AG062817-03 |
|
NIA |
2021 |
|
|
ADNI Psychometrics |
| 5 R01 AG029672-10 |
|
NIA |
2021 |
|
|
Prognostic calculators for patients with Alzheimers disease and related dementias |
| 5 R01 AG057751-04 |
|
NIA |
2021 |
|
|
Statistical method for neural mechanism mediating and moderating cognitive system in Alzheimers disease and aging research. |
| 5 R01 AG062578-02 |
|
NIA |
2021 |
|
|
Statistical methods to improve reproducibility and reduce technical variability in heterogeneous multimodal neuroimaging studies of Alzheimer’s Disease |
| 5 R01 AG063752-03 |
|
NIA |
2021 |
|
|
Higher Reimbursements for Primary Care Services and the Quality of Care for Dually-Eligible Nursing Home Residents with Alzheimer's Disease and Related Dementias. |
| 5 R01 AG063935-02 |
|
NIA |
2021 |
